About

At HyperFlex Medical, we believe it’s time to rethink bunion care. For too long, patients with mild-to-moderate deformities – roughly 93% of those suffering from bunions^1,2 – have been told to wait until their condition worsens enough to warrant invasive bone-cutting surgery. We developed the HyperFlex® Bunion Correction System to change that.

HyperFlex is a bone-preserving, minimally invasive solution designed to address what patients care about most: less pain, faster recovery, and fewer complications. Backed by FDA 510(k) clearance, a growing body of mechanical testing, and a robust IP portfolio (3 U.S. and 3 EU patents issued, with more in process), HyperFlex represents a smarter path forward – for patients, providers, and practices alike.

With a lean business model and experienced leadership, we’re focused on scaling adoption through strong specialty distributors in key orthopedic and podiatric markets. Capturing even 1% of the currently unaddressed market represents a $176MM revenue opportunity at our average selling price (ASP). But more than that, it represents a meaningful shift in how and when we treat bunions.